昂利康化学原料药布比卡因上市申请获批

Core Viewpoint - Anglikon has received approval from the National Medical Products Administration for its chemical raw material drug, Bupivacaine, which meets the registration requirements for pharmaceuticals [1] Group 1: Company Information - Anglikon announced the receipt of the approval notice for the marketing application of Bupivacaine [1] - Bupivacaine is primarily used in clinical settings for local anesthesia and postoperative analgesia [1]